| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4013542 | Journal of American Association for Pediatric Ophthalmology and Strabismus | 2015 | 4 Pages |
Abstract
EI lowered IOP to within an acceptable range with no significant adverse events. In several patients it was the only pharmacologic agent that was successful.
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Courtney L. MD, Rupal H. MD, M. Edward MD,